Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by EQRx, Inc.

EQRx Resets to Focus on Clinically Differentiated Medicines, Leveraging $1.3 Billion Cash Position; Reports First Quarter 2023 Financial Results
From EQRx, Inc.
Via GlobeNewswire
Tickers EQRX
EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023
From EQRx, Inc.
Via GlobeNewswire
Tickers EQRX
EQRx Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Progress
From EQRx, Inc.
Via GlobeNewswire
Tickers EQRX
EQRx to Present at the 41st Annual J.P. Morgan Healthcare Conference
From EQRx, Inc.
Via GlobeNewswire
Tickers EQRX
EQRx Announces Acceptance of Marketing Authorization Application by the UK’s Medicines and Healthcare Products Regulatory Agency for Sugemalimab in Metastatic Non-small Cell Lung Cancer
From EQRx, Inc.
Via GlobeNewswire
Tickers EQRX
EQRx Announces Acceptance of Marketing Authorization Application by the European Medicines Agency for Aumolertinib in EGFR-Mutated Non-small Cell Lung Cancer
From EQRx, Inc.
Via GlobeNewswire
Tickers EQRX
EQRx Provides Portfolio and U.S. Commercial Strategy Updates; Reports Third Quarter 2022 Financial Results
From EQRx, Inc.
Via GlobeNewswire
Tickers EQRX
EQRx to Participate in the Jefferies 2022 London Healthcare Conference
From EQRx, Inc.
Via GlobeNewswire
Tickers EQRX
EQRx to Hold Third Quarter 2022 Financial Results Conference Call on Thursday, November 10, 2022
From EQRx, Inc.
Via GlobeNewswire
Tickers EQRX
EQRx to Hold Second Quarter 2022 Financial Results Conference Call on Thursday, August 11, 2022
From Eqrx, Inc.
Via GlobeNewswire
Tickers EQRX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.